Sources: Pickart & Margolina, Int J Mol Sci 2018 (PMID: 29986520) | Pickart et al., BioMed Res Int 2015 (PMID: 26236449) Security Profile & Chemical Identity Molecular specifications and documented tolerance in clinical studies GHK-Cu Chemical Identity Natural copper complex of the tripeptide glycyl-L-histidyl-L-lysine GHK-Cu Tolerance & Status Safety data from clinical and cosmetic studies Published Clinical & Preclinical Data Key studies published in Int J Mol Sci, BioMed Res Int and dermatological journals -55.8% Reduction in wrinkle volume after 12 weeks of topical application of GHK-Cu cream Anti-Aging Results (12 weeks) 4 000+ Human genes modulated by GHK-Cu (31.2% of the genome) Genomic Impact + 70 % Increased collagen synthesis in human skin fibroblasts Collagen Stimulation Comparison Published Clinical & Preclinical Data Key studies published in Int J Mol Sci, BioMed Res Int and dermatological journals -55.8% Reduction in wrinkle volume after 12 weeks of topical application of GHK-Cu cream Anti-Aging Results (12 weeks) 4 000+ Human genes modulated by GHK-Cu (31.2% of the genome) Genomic Impact + 70 % Increased collagen synthesis in human skin fibroblasts Collagen Stimulation Comparison Important Notice Search Only Not intended for human consumption

Instead of focusing on restriction or quick fixes, they prioritize how your body feels and functions on the medication
The bivalent degrader, designated GS-6791, is the first development candidate resulting from the previously announced Nurix-Gilead collaboration to develop and commercialize a pipeline of innovative targeted protein degradation therapies
Tri-Amino Acid Injections Tri-Amino Acid injections deliver a blend of essential amino acids to support circulation, recovery, and metabolic function
Johannessen H, Revesz D, Kodama Y, Cassie N, Skibicka KP, Barrett P, et al